Crispr Therapeutics shares owned by Gould Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gould Capital
from 13F filings
Historical chart of Gould Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Gould Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Gould Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.5k | 70 | 64.81 |
| 2025-06-30 | $3.4k | 70 | 48.64 |
| 2025-03-31 | $2.4k | 70 | 34.03 |
| 2024-12-31 | $2.8k | 70 | 39.36 |
| 2024-09-30 | $4.9k | 105 | 46.98 |
| 2024-06-30 | $5.7k | 105 | 54.01 |
| 2024-03-31 | $7.2k | 105 | 68.16 |
| 2023-12-31 | $6.6k | 105 | 62.60 |
| 2023-09-30 | $4.7k | 110 | 42.41 |
| 2023-06-30 | $6.2k | 110 | 56.14 |
| 2023-03-31 | $5.0k | 110 | 45.23 |
| 2022-12-31 | $3.7k | 90 | 40.66 |
| 2022-09-30 | $6.0k | 90 | 66.67 |
| 2022-06-30 | $5.0k | 90 | 55.56 |
| 2022-03-31 | $6.0k | 90 | 66.67 |
| 2021-12-31 | $7.0k | 90 | 77.78 |